Literature DB >> 21900658

At Virginia Mason, collaboration among providers, employers, and health plans to transform care cut costs and improved quality.

C Craig Blackmore1, Robert S Mecklenburg, Gary S Kaplan.   

Abstract

Virginia Mason Medical Center in Seattle has worked in collaboration with health plans and employers to facilitate development of standardized approaches to care of patients with common conditions. These efforts have eliminated unnecessary treatment and decreased costs to employers, health plans, patients, and providers. We describe our collaborative approach and illustrate it with the example of improved treatment for patients with uncomplicated headache, for which we have achieved 91 percent patient satisfaction, decreased use of advanced imaging by 23 percent, and provided same-day appointments in 95 percent of cases. As a model for improving quality while reducing cost, the Virginia Mason experience demonstrates that a multispecialty group practice, hospital, employers, and health plans can define quality and align performance and payment along common goals.

Entities:  

Mesh:

Year:  2011        PMID: 21900658     DOI: 10.1377/hlthaff.2011.0291

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  3 in total

Review 1.  Multiple injections for low back pain: What's the future?

Authors:  Oluwatobi O Onafowokan; Nicola F Fine; Francis Brooks; Oliver M Stokes; Timothy Wr Briggs; Mike Hutton
Journal:  Eur Spine J       Date:  2020-01-01       Impact factor: 3.134

2.  Time to Align Coverage with Evidence for Treatment of Back Pain.

Authors:  Daniel C Cherkin; Richard A Deyo; Harley Goldberg
Journal:  J Gen Intern Med       Date:  2019-06-26       Impact factor: 5.128

3.  Towards a taxonomy for integrated care: a mixed-methods study.

Authors:  Pim P Valentijn; Inge C Boesveld; Denise M van der Klauw; Dirk Ruwaard; Jeroen N Struijs; Johanna J W Molema; Marc A Bruijnzeels; Hubertus Jm Vrijhoef
Journal:  Int J Integr Care       Date:  2015-03-04       Impact factor: 5.120

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.